EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine

Eteri Machavariani, Kostyantyn Dumchev, Iryna Pykalo, Myroslava Filippovych, Roman Ivasiy, Denise Esserman, Lynn M Madden, Daniel J Bromberg, Marwan Haddad, Olga Morozova, Bachar Ahmad, David Oliveros Gómez und 3 weitere

Contemporary Clinical Trials · 2024

DOI: 10.1016/j.cct.2024.107690 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von Eteri Machavariani und 14 weiteren Autor:innen. Beteiligte Einrichtung: Section of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, United States of America. Electronic address: eteri.machavar…. Hauptthemen laut MEDLINE: Opiate Substitution Treatment, Opioid-Related Disorders, Primary Health Care. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NCATS NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Ukraine has high HIV prevalence, concentrated among people who inject drugs (PWID), mostly of opioids. Maintenance on opioid agonist therapies (OAT) is the most effective evidence-based treatment for opioid use disorder. As PWID experience high morbidity and mortality from preventable and treatable non-communicable diseases, international agencies recommend integrating OAT into primary care centers (PCC). METHODS: A randomized, type-2 hybrid implementation trial was carried out to compare outcomes of OAT integration in PCC to OAT delivery at specialty treatment centers (STC) - standard-of-care. Tele-education supporting PCC providers in managing OAT, HIV, tuberculosis and non-communicable diseases along with pay-for-performance incentives were used to facilitate implementation. Consenting patients underwent 1:2 randomization to either STC or PCC. Quality health indicators (QHIs), a composite percentage of recommended primary and specialty services accessed by patients (blood/urine tests, cancer screenings, etc.), were defined as efficacy outcomes and were assessed by participant self-report at baseline and every 6 months over 24 months and electronic chart reviews after the completion of the follow-up. The primary outcome is defined as the difference in composite QHI scores at 24 months, in which a repeated measures likelihood-based mixed model with missing at random assumptions will be used. Providers at PCC completed surveys at baseline, 12 and 24 months to assess implementation outcomes including changes in stigma and attitudes towards OAT and PWID. PRELIMINARY RESULTS: Among the 1459 participants allocated to STC (N = 509) or PCC (N = 950), there were no differences in clinical and demographic characteristics. Self-reported prevalences were available for HIV (42 %), HCV (57 %), and prior tuberculosis (17 %). Study retention at 6, 12, 18, and 24 months was as 91 %, 85 %, 80 %, and 74 %, respectively. CONCLUSION: PWID have a high prevalence of medical comorbidities and integrating OAT into primary care settings has the potential to improve the health of PWID. Findings from this study can help guide implementation of integrated care in Ukraine and throughout similar low-resource, high-burden countries in the Eastern European and Central Asian region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opiate Substitution TreatmentOpioid-Related DisordersPrimary Health CareAdultFemaleHumansMaleMiddle AgedBuprenorphineHIV InfectionsMethadoneProspective StudiesUkraine

Stichwörter der Autor:innen

Implementation scienceIntegrated careOpioid agonist therapies (OAT)OpioidsPeople who inject drugs (PWID)Ukraine

Substanzen

BuprenorphineMethadone

Autor:innen und Institutionen

  • Section of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, United States of America. Electronic address: eteri.machavariani@yale.edu.
  • Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
  • European Institute of Public Health Policy, Kyiv, Ukraine.
  • Section of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, United States of America.
  • Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT, United States of America.
  • Section of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, United States of America; APT Foundation, New Haven, CT, United States of America.

Förderung

  • NIDA NIH HHS
  • NCATS NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Machavariani, E., Dumchev, K., Pykalo, I., Filippovych, M., Ivasiy, R., Esserman, D., Madden, L. M., Bromberg, D. J., Haddad, M., Morozova, O., Ahmad, B., Gómez, D. O., Farnum, S. O., Dvoriak, S., & Altice, F. L. (2024). Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107690

Vancouver

Machavariani E, Dumchev K, Pykalo I, Filippovych M, Ivasiy R, Esserman D, et al. Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2024.107690

BibTeX
@article{Machavariani2024,
  author = {Machavariani, Eteri and Dumchev, Kostyantyn and Pykalo, Iryna and Filippovych, Myroslava and Ivasiy, Roman and Esserman, Denise and Madden, Lynn M and Bromberg, Daniel J and Haddad, Marwan and Morozova, Olga and Ahmad, Bachar and Gómez, David Oliveros and Farnum, Scott O and Dvoriak, Sergii and Altice, Frederick L},
  title = {Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine},
  journal = {Contemporary Clinical Trials},
  year = {2024},
  doi = {10.1016/j.cct.2024.107690}
}
Kostenlos starten →